The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo Group

NCT00617474 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Transplantation, Kidney

Interventions

DRUG: Erythropoietin
DRUG: Placebo

Sponsor

Labbafinejhad Hospital

Collaborators

[object Object]